Prescription Drugs Market Size to touch USD 1,890 Billion by 2030
The report analyzes and forecasts the Prescription Drugs Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Prescription Drugs Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Prescription Drugs Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Prescription Drugs Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2530
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The global prescription drugs companies profiled in the report include Novartis AG, Pfizer Inc., F.Hoffmann-La Roche Ltd, Sanofi, Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbvie, Inc., AstraZeneca, and others.
The major market segments of Prescription Drugs Market are as below:
Prescription Drugs Market By Product Type
- Generics
- Orphan
- Other Prescription Drugs
Prescription Drugs Market By Therapy
- Oncology
- Anti-diabetics
- Vaccines
- Sensory organs
- Immunosuppressant’s
- Anticoagulants
- Others
Prescription Drugs Market By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Prescription Drugs Market
1.1. Definition and Scope
1.1.1. Definition of Prescription Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Prescription Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Prescription Drugs Market By Product Type
1.2.3. Prescription Drugs Market By Therapy
1.2.4. Prescription Drugs Market By Distribution Channel
1.2.5. Prescription Drugs Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Prescription Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Prescription Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Prescription Drugs Market By Product Type
4.1. Introduction
4.2. Prescription Drugs Revenue By Product Type
4.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Product Type, 2018-2030
4.2.2. Generics
4.2.2.1. Generics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Orphan
4.2.3.1. Orphan Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Others Prescription Drugs
4.2.4.1. Others Prescription Drugs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Prescription Drugs Market By Therapy
5.1. Introduction
5.2. Prescription Drugs Revenue By Product Type
5.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Product Type, 2018-2030
5.2.2. Oncology
5.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Anti-Diabetics
5.2.3.1. Anti-Diabetics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Vaccines
5.2.4.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Sensory Organs
5.2.5.1. Sensory Organs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Immunosuppressant’s
5.2.6.1. Immunosuppressant’s Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Anticoagulants
5.2.7.1. Anticoagulants Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.8. Others
5.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Prescription Drugs Market By Distribution Channel
6.1. Introduction
6.2. Prescription Drugs Revenue By Distribution Channel
6.2.1. Prescription Drugs Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Retail Pharmacies & Drug Stores
6.2.3.1. Retail Pharmacies & Drug Stores Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Online Pharmacies
6.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Prescription Drugs Market By Country
7.1. North America Prescription Drugs Market Overview
7.2. U.S.
7.2.1. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
7.2.2. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
7.2.3. U.S. Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
7.3. Canada
7.3.1. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
7.3.2. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
7.3.3. Canada Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Prescription Drugs Market By Country
8.1. Europe Prescription Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
8.2.2. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.2.3. U.K. Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.3. Germany
8.3.1. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
8.3.2. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.3.3. Germany Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.4. France
8.4.1. France Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
8.4.2. France Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.4.3. France Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.5. Spain
8.5.1. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
8.5.2. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.5.3. Spain Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
8.6.2. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.6.3. Rest of Europe Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Prescription Drugs Market By Country
9.1. Asia Pacific Prescription Drugs Market Overview
9.2. China
9.2.1. China Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.2.2. China Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.2.3. China Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.3. Japan
9.3.1. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.3.2. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.3.3. Japan Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.4. India
9.4.1. India Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.4.2. India Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.4.3. India Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.5. Australia
9.5.1. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.5.2. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.5.3. Australia Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.6. South Korea
9.6.1. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.6.2. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.6.3. South Korea Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
9.7.2. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.7.3. Rest of Asia-Pacific Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Prescription Drugs Market By Country
10.1. Latin America Prescription Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.2.2. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.2.3. Brazil Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3. Mexico
10.3.1. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.3.2. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.3.3. Mexico Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.4.2. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.4.3. Rest of Latin America Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Prescription Drugs Market By Country
11.1. Middle East & Africa Prescription Drugs Market Overview
11.2. GCC
11.2.1. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.2.2. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.2.3. GCC Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3. South Africa
11.3.1. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.3.2. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.3.3. South Africa Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.4.2. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.4.3. Rest of Middle East & Africa Prescription Drugs Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Prescription Drugs Market
12.1. Prescription Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Prescription Drugs Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Novartis AG
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Novartis AG 2021 Prescription Drugs Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Pfizer Inc.
13.3. F.Hoffmann-La Roche Ltd
13.4. Sanofi
13.5. Johnson & Johnson Services, Inc.
13.6. Merck & Co., Inc.
13.7. Abbvie, Inc.
13.8. AstraZeneca
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2530
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
